• Publications
  • Influence
Malignant migrating partial seizures in infancy: An epilepsy syndrome of unknown etiology
  • G. Coppola
  • Medicine, Psychology
    Epilepsia
  • 1 May 2009
The syndrome of malignant migrating partial seizures in infancy was first reported in 1995, and is now included among the childhood epilepsy syndromes in development in the proposal of the revision
Lamotrigine versus Valproic Acid as First‐line Monotherapy in Newly Diagnosed Typical Absence Seizures: An Open‐label, Randomized, Parallel‐group Study
TLDR
To compare the efficacy of lamotrigine (LTG) and valproic acid (VPA) in newly diagnosed children and adolescents with typical absence seizures is compared.
The metabolic syndrome in overweight epileptic patients treated with valproic acid
TLDR
The objective was to evaluate the presence of metabolic syndrome in children and adolescents treated with valproate (VPA) and to identify patients at high-risk for metabolic syndrome.
A multicenter, randomized, placebo‐controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy
Purpose:  To evaluate the potential efficacy of levetiracetam as an antiabsence agent in children and adolescents with newly diagnosed childhood or juvenile absence epilepsy.
Bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy
TLDR
Assessment of bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy found no significant difference in BMD between children with and without epilepsy.
...
1
2
3
4
5
...